Unibest

Pharmaceutical intermediates

Peramivir Intermediates

3 pharmaceutical intermediates for Peramivir. Indication: Influenza, Human.

提交项目All intermediates

About Peramivir

Originator
Biocryst Pharmaceuticals, Inc
Indication
Influenza, Human
Approved Date
12/19/2014
DS/DP
02/12/2027

Available intermediates

3 intermediates currently listed for Peramivir. Request specifications, documentation or a quotation for any item below.

Peramivir intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1S,4R)-methyl 4-(Boc-amino)cyclopent-2-enecarboxylate168683-02-1//
(3aR,4R,6S,6aS)-4-(tert-butoxycarbonylaMino)-3- (pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylic acid316173-28-1//
(3aR,4R,6S,6aS)-4-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic Acid Methyl Ester229613-93-8//

Other programs under P

PacritinibPalbociclibParecoxib sodiumParicalcitolPaxlovidPazopanib HydrochloridePeficitinib HydrobromidePemafibrate

Building toward Peramivir?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →